BGM Group Ltd. (BGM:NASDAQ) closed at $7.88 on November 13, 2026, down 1.69% on the day. The stock trades 97.2% below its 52-week high of $285.00 and 22.1% above its 52-week low of $6.45. Over the past year, it lost 97.1%. BGM Group Ltd. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, BGM closed higher on 104 days (41%). Its best day was June 10, 2026 (+25.00%) and its worst was February 4, 2026 (-38.08%). The stock moved 10% or more in a single session 37 times. It opened at least 5% above the previous day's high 1 time.
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue.
Find more stocks like BGM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.